Medfield Diagnostics AB (publ)

NGM:MEDF Rapporto sulle azioni

Cap. di mercato: SEK 23.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Medfield Diagnostics Gestione

Gestione criteri di controllo 0/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Bjorn Larsson

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione1.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

May 12
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Dec 29
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

Sep 07
Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

AMMINISTRATORE DELEGATO

Bjorn Larsson

less than a year

Mandato

Mr. Björn Larsson served as Chief Executive Officer at RLS Global AB (publ) since October 01, 2022 until July 2023 and was its Member of Management Board since 2022 until July 2023. He serves as Chief Exec...


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Bjorn Larsson
CEO & Director1.8yrsNessun datoNessun dato
Wigge Jacobsson
Directorno dataSEK 58.35k0.0096%
SEK 2.3k
Mats Andersson
Chairman of the Boardless than a yearNessun dato0.0013%
SEK 297.9
Goran Roos
Independent Director1.8yrsNessun datoNessun dato
Mikael Elam
Directorless than a yearNessun dato0.020%
SEK 4.6k

1.3yrs

Durata media

Consiglio di amministrazione esperto: MEDF's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.